Novilla Pharmaceuticals is an early stage biotech company developing two game changing technologies developed by a former Harvard professor.
The company is backed by high profile investors including the longest serving former Head White House Physician. The company was founded by successful entrepreneurs with over $1b in exits under their belt.
We closed a $3M seed round 2 years ago, and we are currently raising our Series A.
The first drug under development utilizes Xanthine Oxidase to induce immunogenic cell death in a process that has the potential to make 70% of cancers recognizable and therefore destroyed by the body’s own immune system
The second set of drugs utilize a precise delivery mechanism platform that uses charged ions to deliver medications through the dermal layer directly to nerves. This allows us to administer medications directly to the site of action and avoid the bloodstream completely- eliminating side effects and addiction risks for already effective drugs.
Highly competitive salary
Perks include: unlimited paid time off, travel stipend, health care, limitless office snacks, and more!
We are hiring:
2 PhD/MS/MDs (1 in oncology, 1 for the precise delivery mechanism)
1 BA/BS for oncology